(Press-News.org) SAN FRANCISCO, CA—August 6, 2012— Scientists at the Gladstone Institutes have discovered that an FDA-approved anti-epileptic drug reverses memory loss and alleviates other Alzheimer's-related impairments in an animal model of the disease.
Scientists in the laboratory of Lennart Mucke, MD, who directs neurological research at Gladstone, conducted the research on mice genetically modified to simulate key aspects of Alzheimer's disease. In the study, they show how levetiracetam—a drug commonly prescribed for patients who suffer from epilepsy—suppresses abnormal brain activity and restores memory function in these mice. They are publishing their findings online today in the Proceedings of the National Academy of Sciences.
The news comes at a critical time of renewed focus on this most prevalent of neurodegenerative diseases—and amid a dearth of medications that prevent, halt or reverse the increasingly common condition. Alzheimer's afflicts 5.4 million people in the United States alone—a figure expected to nearly triple by 2050.
"For the millions of people suffering from Alzheimer's worldwide, we have no effective drug to prevent or reverse memory loss—the hallmark symptom of this ultimately fatal disease," said Dr. Mucke, who is also a professor of neurology and neuroscience at the University of California, San Francisco (UCSF), with which Gladstone is affiliated. "This study builds on our earlier findings linking Alzheimer's and epilepsy. It provides new insights into the processes underlying memory loss in Alzheimer's and demonstrates the ability of an anti-epileptic drug to block these processes."
Healthy activity in neuronal networks is critical for essential brain functions such as memory. Alzheimer's wreaks havoc on these brain networks, causing disruptions that occasionally escalate into epileptic seizures.
"But whether such neuronal-network disruptions also impair memory was unknown," said Gladstone Postdoctoral Fellow Pascal Sanchez, PhD, who is the paper's lead author. "So we screened seven FDA-approved anti-epileptic medications—including levetiracetam—in our Alzheimer's mouse model to see if minimizing these network disruptions could improve memory."
When the Gladstone scientists administered levetiracetam to the mice, they found that abnormal network activity in their brains dropped by 50% in less than a day. After two weeks of treatment, the neurons' ability to communicate with each other improved. The mice also showed better learning and memory in a maze test. Finally, the researchers observed that several proteins that are important for healthy brain function returned to normal levels.
"We are now building on these findings and working to identify the precise mechanism by which this drug reduces brain-network dysfunction and improves memory in our mouse models," said Dr. Sanchez.
The relevance of this discovery to people with Alzheimer's disease is underscored by research that scientists at Johns Hopkins University published just a few months ago. Their study revealed beneficial effects of levetiracetam in a small group of patients with mild cognitive impairment—a condition that often precedes Alzheimer's. Still, further research is required before the drug is prescribed for Alzheimer's disease.
"Until larger human trials have been completed, we caution against any off-label use of levetiracetam," Dr. Mucke said. "But the consistency between our findings and those just obtained by our colleagues at Johns Hopkins is truly remarkable and, in my opinion, merits additional clinical trials."
###Other scientists who participated in this research at Gladstone include Lei Zhu, PhD, Keith Vossel, MD, Anna Orr, PhD, Nino Devidze, PhD, Gui-Qiu Yu, MS, Laure Verret, PhD, and Jorge Palop, PhD. Funding came from a wide variety of sources, including the National Institutes of Health, the National Center for Research Resources, the Alzheimer's Disease Research Center at UCSF and the S.D. Bechtel, Jr. Foundation.
About the Gladstone Institutes
Gladstone is an independent and nonprofit biomedical-research organization dedicated to accelerating the pace of scientific discovery and innovation to prevent, treat and cure cardiovascular, viral and neurological diseases. Gladstone is affiliated with the University of California, San Francisco.
Gladstone scientists discover that epilepsy drug reverses memory loss in animal model of AD
ELSE PRESS RELEASES FROM THIS DATE:
VIDEO: Harry Ostrer, M.D., discusses how his research into a new genetic analysis focusing on Jews from North Africa has provided an overall genetic map of the Jewish Diasporas. Dr.... Click here for more information. August 6, 2012 — (Bronx, NY) — A new genetic analysis focusing on Jews from North Africa has provided an overall genetic map of the Jewish Diasporas. The findings support the historical record of Middle Eastern Jews settling in North Africa during Classical Antiquity, ...
Specially designed comprehensive behavioral therapy is more effective than sessions offering patient support and education in helping adults with Tourette syndrome manage their tics – sudden, repetitive motions or vocalizations – according to a study in the August issue of Archives of General Psychiatry. The findings come from a team of investigators at Massachusetts General Hospital (MGH)/Harvard Medical School, Yale University, the University of Texas Health Science Center at San Antonio, and other institutions. "The program we tested, which teaches patients new ways ...
CHICAGO – Weight training was linked with a reduced risk of type 2 diabetes in a study of male health professionals, and those men who engaged in weight training and aerobic exercise for at least 150 minutes a week had the greatest reduction in risk, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication. Regular physical activity is a cornerstone in the prevention and management of type 2 diabetes mellitus (T2DM), but the role of weight training in the primary prevention of the disease is largely unknown, according to ...
CHICAGO – Higher levels of physical activity were related to lower risk of death in patients with diabetes, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication. Increased physical activity (PA) has long been considered a key element in diabetes management. Patients with diabetes are at higher risk for cardiovascular disease (CVD) and premature death, so researchers note it is important to determine whether PA can produce similar beneficial effects in this high-risk population. While other studies have suggested that ...
Boston, MA – Men who do weight training regularly—for example, for 30 minutes per day, five days per week—may be able to reduce their risk of type 2 diabetes by up to 34%, according to a new study by Harvard School of Public Health (HSPH) and University of Southern Denmark researchers. And if they combine weight training and aerobic exercise, such as brisk walking or running, they may be able to reduce their risk even further—up to 59%. This is the first study to examine the role of weight training in the prevention of type 2 diabetes. The results suggest that, because ...
CHICAGO – The odds of undergoing cranial computed tomography (CT) among children with minor blunt head trauma who were at higher risk for clinically important traumatic brain injury did not appear to differ by race/ethnicity in a secondary analysis of a study of injured children, according to a report in the August issue of Archives of Pediatrics & Adolescent Medicine, a JAMA Network publication. However, there may have been differences for children at intermediate or lowest risk. Traumatic brain injury (TBI) is a leading cause of pediatric illness and death in the U.S., ...
CHICAGO – Treatment with growth hormone-releasing hormone appears to be associated with favorable cognitive effects among both adults with mild cognitive impairment and healthy older adults, according to a randomized clinical trial published Online First by Archives of Neurology, a JAMA Network publication. "Growth hormone-releasing hormone (GHRH), growth hormone and insulinlike growth factor 1 have potent effects on brain function, their levels decrease with advancing age, and they likely play a role in the pathogenesis of Alzheimer disease," the authors write as background ...
CHICAGO – Patients with hoarding disorder exhibited abnormal activity in regions of the brain that was stimulus dependent when deciding what to do with objects that did or did not belong to them, according to a report in the August issue of Archives of General Psychiatry, a JAMA Network publication. Hoarding disorder (HD) is defined as the excessive collection of objects and an inability to discard them. It is characterized by marked avoidance of decisions about possessions, according to the study background. David F. Tolin, Ph.D., of the Institute of Living, Hartford, ...
White children are more likely to receive cranial (head) CT scans in an emergency department following minor head trauma, compared with African-American or Hispanic children, a study published by researchers at UC Davis has found. The study findings do not indicate that CT (computed tomography) scans are underused in African-American and Hispanic children. Rather, the researchers suggested that white children may receive too many CT scans and thus may be exposed to unnecessary radiation. The results are online and appear in the August issue of the Archives of Pediatrics ...
Just as differences in song can be used to distinguish one bird species from another, the pips and squeaks bats use to find prey can be used to identify different species of bat. Now, for the first time, ecologists have developed a Europe-wide tool capable of identifying bats from their echolocation calls. The new free online tool – iBatsID – will be a major boost to conserving bats, whose numbers have declined significantly across Europe over the past 50 years. Details are published today in the British Ecological Society's Journal of Applied Ecology. Working with ...